316 related articles for article (PubMed ID: 12874015)
41. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
Xu JJ; Yao K; Yu CJ; Chen X; Lu MP; Sun H; Li BZ; Ding CN; Zhou F
Auris Nasus Larynx; 2006 Dec; 33(4):441-6. PubMed ID: 16934422
[TBL] [Abstract][Full Text] [Related]
42. Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity.
Tatsumi T; Huang J; Gooding WE; Gambotto A; Robbins PD; Vujanovic NL; Alber SM; Watkins SC; Okada H; Storkus WJ
Cancer Res; 2003 Oct; 63(19):6378-86. PubMed ID: 14559827
[TBL] [Abstract][Full Text] [Related]
43. Efficient stimulation of T cell responses by human IFN-alpha-induced dendritic cells does not require Toll-like receptor triggering.
Bracci L; Schumacher R; Provenzano M; Adamina M; Rosenthal R; Groeper C; Zajac P; Iezzi G; Proietti E; Belardelli F; Spagnoli GC
J Immunother; 2008 Jun; 31(5):466-74. PubMed ID: 18463538
[TBL] [Abstract][Full Text] [Related]
44. Intracellular delivery of major histocompatibility complex class I-binding epitopes: dendritic cells loaded and matured with cationic peptide/poly(I:C) complexes efficiently activate T cells.
Haenssle HA; Riedl P; Buhl T; Schardt A; Rosenberger A; Schön MP; Schirmbeck R
Exp Dermatol; 2010 Jan; 19(1):19-28. PubMed ID: 19758325
[TBL] [Abstract][Full Text] [Related]
45. Assessing vaccine potency using TCRmimic antibodies.
Neethling FA; Ramakrishna V; Keler T; Buchli R; Woodburn T; Weidanz JA
Vaccine; 2008 Jun; 26(25):3092-102. PubMed ID: 18353510
[TBL] [Abstract][Full Text] [Related]
46. Mature dendritic cells are superior to immature dendritic cells in expanding antigen-specific naive and memory CD8+ T cells.
Tomiyama M; Takahara M; Egawa K; Nieda M
Anticancer Res; 2004; 24(5C):3327-33. PubMed ID: 15515428
[TBL] [Abstract][Full Text] [Related]
47. Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3.
Encabo A; Solves P; Mateu E; Sepúlveda P; Carbonell-Uberos F; Miñana MD
Stem Cells; 2004; 22(5):725-40. PubMed ID: 15342937
[TBL] [Abstract][Full Text] [Related]
48. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
[TBL] [Abstract][Full Text] [Related]
49. Regulation of melanoma epitope-specific cytolytic T lymphocyte response by immature and activated dendritic cells, in vitro.
Mehrotra S; Stevens R; Zengou R; Chakraborty NG; Butterfield LH; Economou JS; Dorsky DI; Mukherji B
Cancer Res; 2003 Sep; 63(17):5607-14. PubMed ID: 14500402
[TBL] [Abstract][Full Text] [Related]
50. Improved efficacy of therapeutic vaccination with dendritic cells pulsed with tumor cell lysate against hepatocellular carcinoma by introduction of 2 tandem repeats of microbial HSP70 peptide epitope 407-426 and OK-432.
Ge C; Xing Y; Wang Q; Xiao W; Lu Y; Hu X; Gao Z; Xu M; Ma Y; Cao R; Liu J
Int Immunopharmacol; 2011 Dec; 11(12):2200-7. PubMed ID: 22015603
[TBL] [Abstract][Full Text] [Related]
51. Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors.
Mortarini R; Anichini A; Di Nicola M; Siena S; Bregni M; Belli F; Molla A; Gianni AM; Parmiani G
Cancer Res; 1997 Dec; 57(24):5534-41. PubMed ID: 9407964
[TBL] [Abstract][Full Text] [Related]
52. Enhanced activation of human T cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells.
Zhu M; Terasawa H; Gulley J; Panicali D; Arlen P; Schlom J; Tsang KY
Cancer Res; 2001 May; 61(9):3725-34. PubMed ID: 11325845
[TBL] [Abstract][Full Text] [Related]
53. OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway.
Jeannin P; Renno T; Goetsch L; Miconnet I; Aubry JP; Delneste Y; Herbault N; Baussant T; Magistrelli G; Soulas C; Romero P; Cerottini JC; Bonnefoy JY
Nat Immunol; 2000 Dec; 1(6):502-9. PubMed ID: 11101872
[TBL] [Abstract][Full Text] [Related]
54. Multiple signals are required for maturation of human dendritic cells mobilized in vivo with Flt3 ligand.
Mosca PJ; Hobeika AC; Colling K; Clay TM; Thomas EK; Caron D; Lyerly HK; Morse MA
J Leukoc Biol; 2002 Sep; 72(3):546-53. PubMed ID: 12223523
[TBL] [Abstract][Full Text] [Related]
55. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells.
Verdijk RM; Mutis T; Esendam B; Kamp J; Melief CJ; Brand A; Goulmy E
J Immunol; 1999 Jul; 163(1):57-61. PubMed ID: 10384099
[TBL] [Abstract][Full Text] [Related]
56. Cryopreservation of monocytes or differentiated immature DCs leads to an altered cytokine response to TLR agonists and microbial stimulation.
Meijerink M; Ulluwishewa D; Anderson RC; Wells JM
J Immunol Methods; 2011 Oct; 373(1-2):136-42. PubMed ID: 21878338
[TBL] [Abstract][Full Text] [Related]
57. [Immune responses of dendritic cells after loaded with cytotoxicity T lymphocyte epitope based peptide of human alpha-fetoprotein (hAFP)].
Guo J; Cai M; Wei D; Qin L; Huang J; Wang X
Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):178-80. PubMed ID: 12113671
[TBL] [Abstract][Full Text] [Related]
58. OK-432 synergizes with IFN-γ to confer dendritic cells with enhanced antitumor immunity.
Pan K; Lv L; Zheng HX; Zhao JJ; Pan QZ; Li JJ; Weng DS; Wang DD; Jiang SS; Chang AE; Li Q; Xia JC
Immunol Cell Biol; 2014 Mar; 92(3):263-74. PubMed ID: 24296809
[TBL] [Abstract][Full Text] [Related]
59. TNF-alpha gene-modified dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity in mice.
Zhang W; Yang H; Wang Z; Jim X
Chin Med J (Engl); 2002 Dec; 115(12):1767-71. PubMed ID: 12622920
[TBL] [Abstract][Full Text] [Related]
60. Induction of tolerogenic vs immunogenic dendritic cells (DCs) in the presence of GM-CSF is regulated by the strength of signaling from monophosphoryl lipid A (MPLA) in association with glutathione and fetal hemoglobin gamma-chain.
Khatri I; Alexander C; Brandenburg K; Fournier K; Mach JP; Rietschel ET; Ulmer AJ; Terzioglu E; Waelli T; Gorczynski RM
Immunol Lett; 2009 May; 124(1):44-9. PubMed ID: 19379773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
